GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BZAM Ltd (XCNQ:BZAM) » Definitions » Debt-to-Revenue

BZAM (XCNQ:BZAM) Debt-to-Revenue : 0.60 (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is BZAM Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

BZAM's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was C$38.70 Mil. BZAM's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was C$11.46 Mil. BZAM's annualized Revenue for the quarter that ended in Sep. 2023 was C$84.18 Mil. BZAM's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 was 0.60.


BZAM Debt-to-Revenue Historical Data

The historical data trend for BZAM's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BZAM Debt-to-Revenue Chart

BZAM Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Revenue
Get a 7-Day Free Trial 0.59 1.92 3.64 1.10 0.91

BZAM Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 0.65 0.51 0.67 0.60

Competitive Comparison of BZAM's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, BZAM's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BZAM's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BZAM's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where BZAM's Debt-to-Revenue falls into.



BZAM Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

BZAM's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(6.86 + 37.824) / 49.351
=0.91

BZAM's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(38.701 + 11.464) / 84.18
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2023) Revenue data.


BZAM Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of BZAM's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BZAM (XCNQ:BZAM) Business Description

Traded in Other Exchanges
Address
200 Burrard Street, Suite 402, Vancouver, BC, CAN, V6C 3L6
BZAM Ltd is a multi-licensed Canadian cannabis producer focused on branded consumer goods, cultivation, processing and people. The BZAM Cannabis family includes core brands BZAM, ness and TABLE TOP, and partner brands FRESH, Dunn Cannabis, SuperFlower and Snackbar. It operates facilities in the Lower Mainland, West Kootenay and Vancouver Island in British Columbia, and sister companies operate facilities in Edmonton, Alberta, as well as retail stores in Winnipeg, Manitoba and Emerald Park, Saskatchewan. The Company's business activities are conducted through two reportable operating segments which both consist of the production and distribution of cannabis and related products: BZAM and TGOD.

BZAM (XCNQ:BZAM) Headlines

No Headlines